The Reliability of Highly Elevated CA 19-9 Levels-Reference-Cited by-同舟云学术

The Reliability of Highly Elevated CA 19-9 Levels

Published:1993 Issue:5-6 Volume:11 Page:275-278
ISSN:0278-0240
Container-title:Disease Markers
language:en
Short-container-title:Disease Markers

Author:

Osswald B. R.¹,Klee F. E.²,Wysocki S.²

Affiliation:

1. Salem Medical Center, Dept. of Medicine, Heidelberg, F.R.C., Germany

2. Salem Medical Center, Dept. of Surgery, Heidelberg, F.R.C., Germany

Abstract

CA 19-9 is used as a tumour marker of the upper gastrointestinal tract. However, extremely elevated CA 19-9 levels are found also in patients with benign diseases. Cholestasis was present in 97.1 % of patients with high elevated CA 19-9, independent of their primary disease. 50% of patients with non-malignant diseases and increased CA 19-9 levels showed liver cirrhosis, cholecystitis, pancreatitis and/or hepatitis. In 8.8% no explanation was found for the extremely high CA 19-9 level. The results provide evidence of different factors influencing the CA 19-9 level.

Publisher

Hindawi Limited

Subject

Biochemistry (medical),Clinical Biochemistry,Genetics,Molecular Biology,General Medicine

Link

http://downloads.hindawi.com/journals/dm/1993/234238.pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE ROLE OF CA 19-9 IN PREDICTING TUMOR RESECTABILITY AND PROGNOSIS IN CARCINOMA HEAD OF THE PANCREAS.;INDIAN JOURNAL OF APPLIED RESEARCH;2021-12-01

2. The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study;Journal of Oncology;2021-02-23

3. Circulating Mucins and Cytokeratins in Aggressive Thyroid Cancers;Atlas of Thyroid and Neuroendocrine Tumor Markers;2018

4. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma;Abdominal Radiology;2017-09-12

5. Advances in biomarkers of biliary tract cancers;Biomedicine & Pharmacotherapy;2016-07